Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02903303
Other study ID # 2016-00236
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 1, 2016
Est. completion date September 1, 2016

Study information

Verified date August 2021
Source Centre Hospitalier Universitaire Vaudois
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study consists in testing the efficacy of hypnosis as an adjuvant treatment for patients suffering from chronic lumbar pain and for whom a facet block is indicated by a doctor in the Centre d'antalgie of CHUV (Centre Hospitalier Universitaire Vaudois), where this study will take place. 5 to 8 patients will be included in this study. The goals of this study are : - Assess the feasibility of such a protocol with more patients - Measure the number of patients necessary to obtain a significant result - Search for possible side effects of the combination of both treatments Every patient in this pilot study will undergo 4 hypnosis sessions within 2 weeks before the facet block. These sessions will be done with an hypnotherapist formed for this kind of treatment. Three times during this study, each patient will have a discussion with the co-investigator :¨ - 1st discussion : just before the first hypnosis session - 2nd discussion : after the 4 hypnosis sessions and just before the facet block, approximately 3 to 4 weeks after the 1st discussion - 3rd discussion : 2 to 4 weeks after the facet block They will allow to obtain several data : - Pain assessment : intensity, localization, variability, characteristics, effects on daily life activities - Anxiety and depression assessment - Expectations assessment : about both treatments and their combination - Efficacy assessment : about both treatments for the patient - Questions about the perceptions of the treatments (prejudice, ...) et possible side effects. These data will then be analysed (quantitative and qualitative analysis, depending on the question type) to fulfill the objectives of the study. will include 5 to 8 people suffering from chronic lumbar pain. The procedure consists in two steps : 1. 4 hypnosis sessions as an adjuvant treatment for number 2 2. a facet block, which is the standard procedure in the Centre d'antalgie in CHUV. There will be no control group, so every patient will participate to the hypnosis sessions and undergo the facet block. All the procedure of the facet block (including contraindications and side effects) are not considered to be part of this study because all patients in this study would have had a facet block if they would not participate in it. The only data that will be collected are questionnaires about several items (pain, anxiety, depression, ...). These questionnaires are filled with the patient at the beginning of the study (day 0), before the facet block (between day 14 and day 21) and 2-4 weeks after it (between day 28 and day 49). There are quantitative and qualitative questions.


Recruitment information / eligibility

Status Terminated
Enrollment 3
Est. completion date September 1, 2016
Est. primary completion date September 1, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Informed consent and signature of the declaration of consent ; - Patient suffering from chronic lumbar pain (> 3 months) - Indication for a facet block ; - Good ability to speak and understand French. Exclusion Criteria: - Previous facet block for the same indication ; - Unability to understand or speak French ; - Unability to understand the written or oral instructions necessary to the protocol application ; - Acute or severe psychiatric decompensation and/or acute psychosocial distress ; - Complex psychosocial situation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Hypnosis
It will consist in 4 hypnosis sessions within 2 weeks mainly for analgesic purpose. The main themes are : 1st session : contact with the therapist, body scan, basic suggestions 2nd session : hypnosis induction followed by suggestions tu build a safe place 3rd session : it is the first complete hypnosis session (induction and specific suggestions against pain) 4th session : very similar to the previous session for the content, focused on auto-hypnosis learning.

Locations

Country Name City State
Switzerland Centre d'antalgie, Centre Hospitalier Universitaire Vaudois Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Vaudois

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Daily pain history During the first encounter (day 0), we will ask the patient since when he/she suffers from daily pain:
Daily pain in general since : < 3 months ; 3-6 months ; 6-12 months ; 1-3 years ; 3-5 years ; 5-10 years ; 10-20 years ; > 20 years
Daily lumbar pain since : < 6 months ; 6-12 months ; 1-3 years ; > 3 years
1st encounter with the co-investigator (day 0)
Primary Change in pain localization For this outcome, the patient is asked to say where is the daily pain and to precise if the pain concerns both sides. If there is more than one localization, the patient is asked to say which pain is the worst for him/her. 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)
Primary Change in neuropathic characteristics of the lumbar pain Neuropathic characteristics (yes/no) :
burning
painful cold
electricity sensation
swarming
tingle
itching
numbness
1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)
Primary Change in lumbar pain intensity Intensity on a scale from 0 (no pain) to 10 (worst pain imaginable) :
Worst pain during the previous week
Lowest pain during the previous week
Average pain during the previous week
1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)
Primary Change in lumbar pain interferences For this outcome, we will ask the patient to tell us how much between 0 (no influence at all) and 10 (complete discomfort) the lumbar pain has on :
A) General activity B) Mood C) Ability to walk D) Usual work E) Relationship with others F) Sleep G) Taste of living
1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)
Primary Change in Anxiety and Depression assessment In this pilot study, we will use the HADS scale (Hospital Anxiety and Depression Scale) to assess the level of anxiety and depression at the beginning of the study (day 0) and at the end of it (day 28-49). The items are the following (on a scale from 0 to 3, depending on the agreement to the sentence) :
I feel tense and angry
I am afraid, just like if something horrible was going to happen to me
I'm worried
I can sit quietly doing nothing and feel relaxed
I experience feelings of fear and feel my stomach tensed
I have ants in my pants and can't stay in place
I experience sudden feelings of panic
I feel the same pleasure to the same things as before
I easily laugh and see things in a good way
I am in a good mood
I feel like I work slowly
I don't take care about my appearance anymore
I'm looking forward to doing some things
I can enjoy a good book or a good TV/radio show
1st and 3rd encounters with the co-investigator (day 0, day 28-49)
Primary Presumed efficacy and expectations about treatments of lumbar pain On a scale from 0 (no efficacy at all) to 10 (completely relieves the pain), the patient assesses the presumed efficacy in general of : (only for the 1st encounter)
Hypnosis alone
Facet block alone
Combination of both
On a scale from 0 to 10, the patient assesses the expectations towards 1), 2) and 3).
1st encounter (day 0)
Primary Efficacy about treatments of lumbar pain On a scale from 0 (no efficacy at all) to 10 (completely relieves the pain), the patient assesses the efficacy of :
Hypnosis alone
Facet block alone
Combination of both
3rd encounter (day 28-49)
Primary Functionality enhancement expectations thanks to hypnosis On a scale from 1 (minimal impact) to 5 (maximal enhancement), the patient assesses how much he/she thinks hypnosis will enhance the ability to :
do sports
practice the professional activity
do your daily activities
enhance your mood
other (free space for the patient to write)
1st encounter (day 0)
Primary Functionality enhancement thanks to hypnosis On a scale from 1 (minimal impact) to 5 (maximal enhancement), the patient assesses how much hypnosis has enhanced his/her ability to :
do sports
practice the professional activity
do your daily activities
enhance your mood
other (same item as in outcome 9)
3rd encounter (day 28-40)
Primary Questions with a qualitative analysis (part 1) During this encounter, we will ask questions to the patient and write down the main subjects mentioned, so that a theme-based analysis can be done with these. The questions are the following :
How do you think hypnosis work ?
What do you think will happen during hypnosis ?
Does it make you experience any emotions ?
What do you think of hypnosis as a therapeutical approach ?
How do you think facet block works ?
What do you think will happen during this intervention ?
What do you think of facet block as a therapeutical approach ?
What is your position about pain-relief drugs ?
Do you use other approaches against pain ? If yes, which one and what does and doesn't work with you ?
Do you have further comments about both treatments ?
1st encounter (day 0)
Primary Questions with a qualitative analysis (part 2) During this encounter, we will ask questions to the patient and write down the main subjects mentioned, so that a theme-based analysis can be done with these. The questions are the following :
How do you feel now about hypnosis as a treatment against pain ?
Did your mind change about hypnosis ? If yes, how and in what ?
Now, do you consider using hypnosis and/or self-hypnosis as a new way to deal with your lumbar pain ?
Do you have further comments about the study or the procedure ?
3rd encounter (day 28-49)
Secondary Security assessment Immediately after the beginning of the study, every patient will be told to report every adverse effect or discomfort during or after an hypnosis session. During the hypnosis session, the therapist will be vigilant about possible negative effects and will help the patient go through it. He will also make a report about it.
Every adverse effect will be discussed in detail with the patient during the 2nd or the 3rd discussion with the co-investigator.
2nd and 3rd encounters (day 14-21, day 24-49)
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain